长期使用利瓦罗克萨班与严重的大动脉狭窄症下大动脉的化有关
Magdalena Kopytek1, Jacek Tarasiuk2, Sebastian Wroński2
1Department of Thromboembolic Disorders, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland; Krakow Centre for Medical Research and Technologies, St. John Paul II Hospital, Krakow, Poland.
The Canadian journal of cardiology
|June 29, 2025
概括
直接口服抗凝剂,如利瓦洛克萨班,可能会减少大动脉狭窄的化. 这项研究发现,在接受Rivaroxaban治疗的患者中,较低的膜化和相关的蛋白质表达.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 生物医学工程 生物医学工程
背景情况:
- 实验室研究表明,直接口服抗凝剂 (DOAC) 抑制了化和炎症.
- 这项研究调查了大动脉狭窄症 (AS) 和心房动症 (AF) 患者的DOAC治疗和降低膜化之间的关联.
研究的目的:
- 评估DOAC治疗是否与AS患者降低膜化相关,这些患者接受AF抗凝药.
主要方法:
- 一项病例控制研究比较了72名严重AS患者和53名用DOACs治疗的AF和严重AS患者.
- 微计算机断层扫描 (micro-CT) 评估了利瓦洛克萨班治疗患者与非抗凝血AS患者的大动脉的化.
- 骨质素,NF-κB和IL-6的膜表达被使用免疫染来评估.
主要成果:
- 里瓦罗克萨班使用者通过微型CT显著降低了体积,表面体积,心血管/心血管比率和最大椎骨厚度.
- 在接受里瓦洛克萨班治疗的患者中,骨质疏松素和NF-κB表达减少,IL-6强度较低.
- 里瓦罗克萨班使用时间与微型CT参数相反相关,与骨质疏松素表达呈正相关.
结论:
- 在AS患者中长期使用里瓦罗克萨班与降低大动脉叶片化有关.
- 这些发现表明,里瓦洛克萨班在缓解膜化进展方面可能发挥作用.
相关概念视频
Aortic Regurgitation III: Medical Management
52
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
52
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
59
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
59
Aortic Regurgitation I: Introduction
45
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
45
Rheumatic Heart Disease I: Introduction
52
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
52
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
128
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
128
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K


